Doctors track new hemophilia drug in babies under 3
NCT ID NCT05248594
Summary
This study collected real-world information about how doctors use the medication emicizumab to prevent bleeding in very young children (ages 0-3) with hemophilia A. Researchers reviewed medical records from 71 children across several treatment centers to understand common dosing practices, how well the drug prevented bleeding, and how surgeries were managed while on the medication. The goal was to gather practical experience to help guide treatment for other young children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital at Montefiore
The Bronx, New York, 10467, United States
-
Comprehensive Center for Hemophilia and Coagulation Disorders (Cornell)
New York, New York, 10065, United States
-
Connecticut Children's Hemophilia Treatment Center - Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
-
Dartmouth Hitchcock Hemophilia Center - Mary Hitchcock Memorial Hospital
Lebanon, New Hampshire, 03766, United States
-
Mary M Gooley Hemophilia Center, Inc.
Rochester, New York, 14621, United States
-
Newark Beth Israel
Newark, New Jersey, 07112, United States
-
Northwell Health Hemostasis and Thrombosis Center
Staten Island, New York, 11030, United States
-
SUNY Upstate Hemophilia Treatment Center - HTC 058
Syracuse, New York, 13210, United States
-
Western NY Blood Care - Research Foundation for SUNY
Buffalo, New York, 14202, United States
-
Yale Hemophilia Treatment Center
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.